Gilead shows support for equitable healthcare for indigenous populations
Pharmaceutical companies are starting to acknowledge their responsibility to making access to medicine equitable to all, and Gilead Sciences are working towards their biggest commitment in this aspect, via a new initiative to enable health equity for Australian and Canadian Indigenous communities.
The initiative is focusing on the transmission of HIV and viral hepatitis in indigenous communities, working to support programmes and break down preconceptions and societal barriers that hinder the quality and access of care people in these communities receive.
To execute the plan, Gilead is working with organisations in the two countries – both indigenous-led – the Lowitja Institute in Australia and CAAN Communities, Alliances & Networks in Canada. Working together, the three organisations are creating a new, US$6 million grant programme, with the aim of spreading the funds out between the countries over the course of three years. The grant aims to provide much needed financial support to activities on the ground, led by organisations and initiatives dedicated to improving healthcare in indigenous communities.
There is a lot more dialogue in recent years surrounding the disparities in health care and subsequently health outcomes in indigenous populations, stemming from colonisation and the resulting oppression experienced by these communities, echoes of which still have a considerable effect today.
When studying the prevalence of these infectious diseases across Australia and Canada, there is a significantly higher rate in indigenous populations compared to in non-indigenous populations. The indigenous communities also encounter comparatively more barriers when looking to gain a diagnosis or access to the required treatment.
“We recognise that the Indigenous communities in both Australia and Canada have unique healthcare needs,” commented Alex Kalomparis, Senior Vice President, Public Affairs, Gilead Sciences. "Gilead's new funding program will help promote engagement in HIV and viral hepatitis care by supporting culturally appropriate solutions that address these needs, while enabling Indigenous people to continue advocating for the care of their communities."
Gilead strongly believe that more is needed than simply funding projects, and that by working closely with, listening to, and being guided by organisations headed by indigenous people, they can help to make a meaningful change in how indigenous communities are supported. By championing culturally important initiatives Gilead are hoping to see improvements in the discrepancy of care and health outcomes in indigenous populations were HIV and viral hepatitis infection prevalence is high.
The grant project is one aspect where Gilead is hoping to support more equitable access to healthcare globally, and combat the HIV epidemic.
Source: Gilead Sciences. Gilead Sciences Announces Its Largest Commitment to Health Equity for Australian and Canadian Indigenous Communities. [Date Accessed 27/07/2023]
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News CPHI Pharma Awards 2024: Meet the winners from the CPHI Celebration
This year we had a lot to celebrate, the 35th Anniversary of CPHI, and our esteemed award winners, of which we included two additional categories this year, the Future Leader award, and Woman of the Year award. -
News CPHI Milan 2024 - From the Floor
Milan and CPHI welcome you to 2024 CPHI Milan! As we celebrate the 35th edition of our flagship CPHI show, editors Vivian Xie and Lucy Chard bring you the latest from the show floor, conference sessions, and innovative solutions from all exhibitors, at... -
News Women in Pharma: C-Suite Journeys in Leading Diversity
In this CPHI Milan special of our monthly series, we sit down with our panel of C-suite executives speaking on the ‘Leading with Diversity: The CEO Journey’ panel at this year’s show. -
News Women in Pharma: A leader's approach to diversity advocacy
In our monthly series on women in the pharmaceutical industry, we interview leading experts in the pharmaceutical supply and value chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Mentorship Programme - building a stronger pharma community
CPHI has a reputation for bringing the pharma industry together, creating a space where partnerships can be formed and nurtured, and relationships can be developed and cultivated between all industry actors. These collaborations encourage growth in the... -
News CPHI Podcast Series: Why we need to consider women in clinical trials
The latest episode of the CPHI Podcast Series with Lucy Chard covers women's health, specifically women's representation in clinical trials, the associated bias, and the impacts on health for this population. -
News Novartis and Viatris latest facing lawsuit over HeLa cell misuse
Global pharmaceutical companies Novartis and Viatris are the latest hit with a lawsuit claim pertaining to alleged misuse of the ‘HeLa’ cell line from the estate of woman whose cancerous tissue cells were taken without consent.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance